Survey
* Your assessment is very important for improving the work of artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the work of artificial intelligence, which forms the content of this project
SANJEEV GUPTA, M.D. Positions: Professor, Department of Medicine, and of Pathology Member, NIH Centers for Liver, Diabetes, and Cancer The Eleazar and Feige Reicher Chair in Translational Medicine, Albert Einstein College of Medicine Director, Translational Technologies, Institute for Clinical and Translational Research, Albert Einstein College of Medicine and Montefiore Medical Center Attending Physician (Gastroenterology and Liver Diseases), Montefiore Medical Center Research interests: Our research is focused on cell therapy with liver-directed applications. This requires insights into the potential of candidate donor cells, including stem cell–derived cells, as well as mechanisms of organ repopulation and disease correction with specific cell types. We established a number of principles for how livers could be repopulated with cells, how genetic and acquired conditions could be corrected in animal models and how specific cell types could be important in these efforts. Most recently, we discovered that paracrine signaling from suitable transplanted cell types, including stem cell–derived cells, could promote liver regeneration and rescue animals in acute liver failure. Similarly, we discovered that liver endothelial cells produce FVIII and corrected hemophilia in a mouse model with endothelial cell transplantation as well as bone marrow transplantation. We are defining the nature of human embryonic and fetal endoderm-derived hepatic and endothelial progenitor cells, and pursuing tissue engineering and cell therapy approaches in models of liver failure, hepatitis, hemophilia and Wilson disease as suitable paradigms for clinical translation. Current grant funding: 1R01 DK088561 (Gupta) NIH/NIDDK 07/01/2011–06/30/2015 Cell transplantation and inflammation 2R01 DK071111 (Gupta) 07/01/2012–06/30/2016 Transplantation of endothelial cells 5P30 DK041296 (Shafritz) NIH/NIDDK (Gupta) 06/01/2009–05/31/2014 Liver pathobiology and gene therapy research core center Director, Special Animals Core NYSTEM C024172 (Bouhassira) NY State Stem Cell Program (Gupta) 04/01/2008–03/30/2013 Shared resources for stem cell research Co-Director, Xenotransplantation Stem Cell Core Five recent publications: 1. Joseph B, Berishvili E, Benten D, Kumaran V, Liponava E, Bhargava K, Palestro C, Kakabadze Z, Gupta S. Isolated small intestinal segments support auxiliary livers with maintenance of hepatic functions. Nat. Med. 2004, 10:749–53. 2. Follenzi A, Benten D, Novikoff P, Faulkner L, Raut S, Gupta S. Transplanted endothelial cells repopulate the liver endothelium and correct the phenotype of hemophilia A mice. J. Clin. Invest. 2008, 118:935–45. 3. Bandi S, Joseph B, Berishvili E, Singhania R, Wu YM, Cheng K, Gupta S. Perturbations in ataxia telangiectasia mutant signaling pathways after drug-induced acute liver failure and their reversal during rescue of animals by cell therapy. Am. J. Pathol. 2011, 178:161–74. 4. Bandi S, Cheng K, Joseph B, Gupta S. Spontaneous origin from human embryonic stem cells of early developmental stage liver cells displaying conjoint meso-endodermal phenotype with hepatic functions. J. Cell. Sci. 2012, 125:1274–83. 5. Follenzi A, Raut S, Merlin S, Sarkar R, Gupta S. Role of bone marrow transplantation for correcting hemophilia A in mice. Blood 2012, 119:5532–42.